- Home
- SABS vs WKSP Comparison
SABS vs WKSP Comparison
Compare SABS & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- WKSP
- Stock Information
- Founded
- SABS 2014
- WKSP 2003
- Country
- SABS United States
- WKSP United States
- Employees
- SABS N/A
- WKSP N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- SABS Health Care
- WKSP Consumer Discretionary
- Exchange
- SABS Nasdaq
- WKSP Nasdaq
- Market Cap
- SABS 15.8M
- WKSP 14.6M
- IPO Year
- SABS N/A
- WKSP N/A
- Fundamental
- Price
- SABS $2.02
- WKSP $3.49
- Analyst Decision
- SABS Strong Buy
- WKSP Strong Buy
- Analyst Count
- SABS 5
- WKSP 3
- Target Price
- SABS $10.00
- WKSP $12.83
- AVG Volume (30 Days)
- SABS 4.3M
- WKSP 314.5K
- Earning Date
- SABS 08-07-2025
- WKSP 08-13-2025
- Dividend Yield
- SABS N/A
- WKSP N/A
- EPS Growth
- SABS N/A
- WKSP N/A
- EPS
- SABS N/A
- WKSP N/A
- Revenue
- SABS $114,698.00
- WKSP $10,211,747.00
- Revenue This Year
- SABS N/A
- WKSP $151.32
- Revenue Next Year
- SABS N/A
- WKSP $74.19
- P/E Ratio
- SABS N/A
- WKSP N/A
- Revenue Growth
- SABS N/A
- WKSP 407.96
- 52 Week Low
- SABS $1.00
- WKSP $2.44
- 52 Week High
- SABS $6.60
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- SABS 42.28
- WKSP 49.39
- Support Level
- SABS $1.85
- WKSP $3.00
- Resistance Level
- SABS $2.26
- WKSP $3.75
- Average True Range (ATR)
- SABS 0.26
- WKSP 0.31
- MACD
- SABS -0.06
- WKSP -0.02
- Stochastic Oscillator
- SABS 16.71
- WKSP 48.51
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.